These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31686463)

  • 1. Toward confirmation of the safety and efficacy of methoxy polyethylene glycol-epoetin beta in anemia treatment in patients on hemodialysis: a Macedonian experience.
    Kacarska-Fotevska I; Volckova N; Ilievska K; Donev D
    Croat Med J; 2019 Oct; 60(5):475-478. PubMed ID: 31686463
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and Efficacy of Methoxy Polyethylene Glycol-epoetin Beta in Anemia Treatment in Patients on Hemodialysis: a Macedonian Experience.
    Kacarska-Fotevska II; Volckova N; Ilievska K; Donev D
    Med Arch; 2020 Apr; 74(2):109-114. PubMed ID: 32577051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Long-Term Safety of C.E.R.A. Maintenance in Pediatric Hemodialysis Patients with Anemia of CKD.
    Fischbach M; Wühl E; Reigner SCM; Morgan Z; Schaefer F
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):81-90. PubMed ID: 29097481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial.
    Locatelli F; Hannedouche T; Fishbane S; Morgan Z; Oguey D; White WB
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1701-1710. PubMed ID: 31420350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA).
    Levin NW; Fishbane S; Cañedo FV; Zeig S; Nassar GM; Moran JE; Villa G; Beyer U; Oguey D;
    Lancet; 2007 Oct; 370(9596):1415-21. PubMed ID: 17950856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methoxy polyethylene glycol epoetin beta].
    Taéron C
    Rev Infirm; 2010 Apr; (159):47-9. PubMed ID: 20432857
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
    Palmer SC; Saglimbene V; Mavridis D; Salanti G; Craig JC; Tonelli M; Wiebe N; Strippoli GF
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010590. PubMed ID: 25486075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous Erythropoietin Receptor Activator for the Treatment of Chronic Dialysis Patients with Renal Anemia in Daily Clinical Practice in Poland: A Non-Interventional, Multi-Center, Pragmatic NAVIGO Trial.
    Nowicki M; Drożdż M; Wajda J; Klatko W; Segiet-Święcicka A
    Nephron; 2024; 148(2):104-112. PubMed ID: 37708860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methoxy Polyethylene Glycol-Epoetin Beta as a Novel Erythropoiesis Stimulating Agent with Possible Nephroprotective and Cardiovascular Protective Effects in Non-Dialysis Chronic Kidney Disease Patients.
    Piotr B; Mariusz S; Jacek R
    Curr Pharm Biotechnol; 2017; 18(4):303-308. PubMed ID: 28137221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methoxy polyethylene glycol-epoetin beta: a review of its use in the management of anaemia associated with chronic kidney disease.
    Curran MP; McCormack PL
    Drugs; 2008; 68(8):1139-56. PubMed ID: 18484803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial.
    Klinger M; Arias M; Vargemezis V; Besarab A; Sulowicz W; Gerntholtz T; Ciechanowski K; Dougherty FC; Beyer U
    Am J Kidney Dis; 2007 Dec; 50(6):989-1000. PubMed ID: 18037099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing regimen and tolerability of methoxy polyethylene glycol-epoetin beta in Chinese dialysis patients.
    Choy BY; Lam MF; Yip T; Tang HL; Wong PN; Chow CC; Yap DY; Chan TM
    Nephrology (Carlton); 2013 Aug; 18(8):533-8. PubMed ID: 23714233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.
    Saglimbene VM; Palmer SC; Ruospo M; Natale P; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD009904. PubMed ID: 28782299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of anemia treatment with methoxy polyethylene glycol-epoetin beta on polymorphonuclear cells apoptosis in predialysis patients with chronic kidney disease.
    Bartnicki P; Majewska E; Kowalczyk M; Baj Z; Banach M; Rysz J
    Pharmacol Rep; 2015 Oct; 67(5):842-5. PubMed ID: 26398374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methoxy polyethylene glycol-epoetin beta: new drug. Pegylated epoetin beta: risk of cardiovascular disorders.
    Prescrire Int; 2008 Oct; 17(97):191. PubMed ID: 19534043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa for anemia in non-dialysis-dependent CKD: a systematic review.
    Alsalimy N; Awaisu A
    Int J Clin Pharm; 2014 Dec; 36(6):1115-25. PubMed ID: 25288147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictors of response to the CERA in chronic hemodialysis treatment-naive by erythropoiesis-stimulating agent].
    Ezziani M; Najdi A; Mikou S; Hanin H; Arrayhani M; Houssaini TS
    Pan Afr Med J; 2015; 20():331. PubMed ID: 26175821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy and safety of continuous erythropoietin receptor activator in dialytic patients with chronic renal anemia: an open, randomized, controlled, multi-center trial].
    Chen N; Qian JQ; Mei CL; Zhang AH; Xing CY; Wang L; Liu WH; Wang M; Chen JH; Liu BC; Hou FF; Chen XM; Zuo L; Shi W; Yu LB; Zhang Y
    Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):502-7. PubMed ID: 22943819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between responsiveness to methoxy polyethylene glycol-epoetin beta and renal survival in patients with non-dialysis-dependent chronic kidney disease: A pooled analysis of individual patient-level data from clinical trials.
    Tsuruya K; Uemura Y; Hirakata H; Kitazono T; Tsubakihara Y; Suzuki M; Ohashi Y
    Nephrology (Carlton); 2017 Oct; 22(10):769-775. PubMed ID: 27312361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time spent on erythropoietin stimulating agents administration in hemodialysis centers in Panama: a time and motion study.
    Chacón-Araya M; Rey-Rodríguez D; Rodríguez De León F; Ramos-Esquivel A; Sunning T
    J Med Econ; 2019 Aug; 22(8):736-741. PubMed ID: 30915883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.